Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Hung Yung Lai, Executive. Director active across 1 company, notably Dawnrays Pharmaceutical (Holdings) Ltd.. Cumulatively, 8 reports have been recorded. Activity tracked since 30 March 2026. The latest transaction was disclosed on 25 June 2026 (Purchase). Regulator: HKEX. All data is openly available.
84,000 shares@ €0.12140.0006% mcap29.2% of flowShareXHKGHKEX:DA20260331E00419
Ideal exit: 25 Dec 2026 (T+270)
8 of 8 declarations
About Hung Yung Lai
Hung Yung Lai is an executive at Dawnrays Pharmaceutical (Holdings) Ltd. He is responsible for managing operations and strategy for the company, which is active in the pharmaceutical sector. His role is essential for the development and innovation of the company.